MyFinsight
Home
About
Contact
vrdn: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, VRDN has $577,138K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
577,138
582,324
Total stockholders equity
502,970
515,169
Total liabilities and stockholders equity
577,138
582,324
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$11,012K
Unbilled revenue
$70,000K
Short-term investments
$321,254K
Cash and cash
equivalents
$169,647K
Other assets
$1,518K
Operating lease
right-of-use asset
$2,582K
Property and equipment,
net
$1,125K
Total current assets
$571,913K
Total assets
$577,138K
Total liabilities and
stockholders equity
$577,138K
Total stockholders
equity
$502,970K
Total liabilities
$74,168K
Accumulated deficit
-$1,218,103K
Accumulated other
comprehensive income (loss)
$363K
Additional paid-in capital
$1,531,003K
Other liabilities
$2,582K
Long-term debt
$20,890K
Total current
liabilities
$50,696K
Common stock, 0.01 par
value 200,000,000...
$822K
Preferred stock-Series
BPreferred Stock
$127,697K
Preferred stock-Series
APreferred Stock
$61,188K
Accrued liabilities
$40,633K
Accounts payable
$10,063K
Buy me a coffee
Viridian Therapeutics, Inc. DE (VRDN)
Viridian Therapeutics, Inc. DE (VRDN)